In 2023, the share of France's scientific publications in pharmacy among the world's top 10% most-cited stood slightly lower than the forecasted values. From 2024 to 2028, there's a predicted steady increase from 8.88% to 9.32%. This indicates a gradual but consistent improvement in the impact of French pharmaceutical research publications.
- Year-on-year growth shows progressive enhancement solidifying France’s position in high-impact pharmaceutical publishing.
- The compound annual growth rate (CAGR) over this period reflects overall positive advancements.
Future trends to watch include increased collaboration and innovation within French pharmaceutical research, which could further bolster citation impact and international recognition.
